Overcoming Barriers to Effective Treatment and Enrollment on Clinical Trials for Black and Underserved Patients With Multiple Myeloma

Learn from a multidisciplinary panel of experts about state-of-the-art care for patients with multiple myeloma and strategies to improve access to care for underserved patient populations with these on-demand roundtable videos and downloadable slides.

Share

Program Content

No activities added yet

No activities added yet

Provided by

ProCE Banner
ProCE Banner

Provided by The Boston University School of Medicine Continuing Medical Education Office (BUSM CME), in collaboration with Boston Medical Center (BMC) and Clinical Care Options (CCO)

Supporters

This activity is supported by independent medical education grants from Bristol Myers Squibb, Karyopharm Therapeutics, Pfizer, Inc., and Regeneron Pharmaceuticals, Inc. This activity is also supported by an educational grant from Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC.

Bristol Myers Squibb

Janssen Pharmaceuticals, Inc., administered by Janssen Scientific Affairs, LLC.

Karyopharm Therapeutics

Pfizer, Inc.

Regeneron Pharmaceuticals, Inc